Takeda Pharmaceutical Co Ltd
TAKCIK 0001395064 · last filing Jul 6, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
648,756 bought / 0 sold
net +648,756 sh
- buys
- 25
- sells
- 0
- insiders active
- 24
Filing tape
Filed Mon, Jul 6, 2026
- +3,800 sh
Gillis Steven — Director
- Granted3,800Ordinary Shares→ 10,400 held
- Returned to company1,152Tax Obligation Award@ $4,931.20→ 0 held
- Granted1,319Tax Obligation Award→ 1,319 held
- +3,800 sh
Maraganore John — Director
- Granted3,800Ordinary Shares→ 10,400 held
- Returned to company1,152Tax Obligation Award@ $4,931.20→ 0 held
- Granted1,319Tax Obligation Award→ 1,319 held
- +3,800 sh
Reed Kimberly A. — Director
- Granted3,800Ordinary Shares→ 10,400 held
- Returned to company1,152Tax Obligation Award@ $4,931.20→ 0 held
- Granted1,319Tax Obligation Award→ 1,319 held
- +1,800 sh
Iijima Masami — Director
- Granted1,800Ordinary Shares→ 14,601 held
- Returned to company2,152Tax Obligation Award@ $4,931.20→ 0 held
- Granted1,937Tax Obligation Award→ 1,937 held
- +3,800 sh
Broussard Bruce D — Director
- Granted3,800American Depositary Shares→ 4,595 held
- Granted1,319Tax Obligation Award→ 1,319 held
- +3,800 sh
Stoffels Paulus — Director
- Granted3,800Ordinary Shares→ 3,800 held
- Granted1,307Tax Obligation Award→ 1,307 held
- +1,800 sh
Kimura Koichiro — Director
- Granted1,800Ordinary Shares→ 1,800 held
- Granted1,937Tax Obligation Award→ 1,937 held
- +1,800 sh
Tsusaka Miki — Director
- Granted1,800Ordinary Shares→ 8,200 held
- Returned to company2,152Tax Obligation Award@ $4,931.20→ 0 held
- Granted1,937Tax Obligation Award→ 1,937 held
- +1,500 sh
Miyabashira Asuka — President, Japan Pharma B.U.
- Granted1,500Ordinary Shares→ 4,500 held
- Returned to company1,022Tax Obligation Award@ $4,931.40→ 0 held
- Granted664Tax Obligation Award→ 1,392 held
- Granted664Tax Obligation Award→ 1,174 held
- Granted666Tax Obligation Award→ 666 held
- +12,300 sh
Furuta Milano — Chief Financial Officer · Director
- Granted12,300Ordinary Shares→ 70,200 held
- Returned to company16,619Tax Obligation Award@ $4,931.50→ 0 held
- Granted4,288Tax Obligation Award→ 11,741 held
- Granted4,288Tax Obligation Award→ 8,482 held
- Granted4,288Tax Obligation Award→ 4,288 held
- +49,558 sh
Platford Giles Richard — President, IBU
- Granted49,558American Depositary Shares→ 346,921 held
- +18,808 sh
Smoter Jennifer Marie — Chief Comm. & Gov. Officer
- Granted18,808American Depositary Shares→ 18,808 held
- +25,078 sh
Ibrahim Ramy Riad Ahmed — President, PDT BU
- Granted25,078American Depositary Shares→ 109,865 held
- +22,570 sh
Greenway Nicola Deidre Petal — Chief Human Resources Officer
- Granted22,570American Depositary Shares→ 94,406 held
- +17,554 sh
Farajallah Awny Samaan Botros — Chief Medical Officer
- Granted17,554American Depositary Shares→ 130,183 held
- +43,886 sh
Furney Natalie Anne Marie — Global General Counsel
- Granted43,886American Depositary Shares→ 235,166 held
- +50,156 sh
Pacheco Rhonda Janice — President, U.S. Business Unit
- Granted50,156American Depositary Shares→ 199,408 held
- +27,586 sh
Pignagnoli Agosti Marcello — Head, Strat. & Port. Dev.
- Granted27,586American Depositary Shares→ 199,934 held
- +37,616 sh
Ricci Gabriele — Chief Data & Tech. Officer
- Granted37,616American Depositary Shares→ 196,742 held
- +30,094 sh
Shannon Elaine Mary — Pres., Global Supply & Quality
- Granted30,094American Depositary Shares→ 87,674 held
- +45,140 sh
Duprey Lauren Rusckowski — Chief Transformation Officer
- Granted45,140American Depositary Shares→ 273,643 held
- +43,886 sh
Bitetti Teresa Marie — President, OBU
- Granted43,886American Depositary Shares→ 302,022 held
- +73,234 sh
Kim Julie So-Young — President and CEO · Director
- Granted50,434American Depositary Shares→ 480,579 held
- Granted22,800Ordinary Shares→ 22,800 held
- Granted7,741Tax Obligation Award→ 7,741 held
- Granted7,741Tax Obligation Award→ 7,741 held
- Granted7,743Tax Obligation Award→ 7,743 held
- +125,390 sh
Plump Andrew Stewart — President, R&D · Director
- Granted125,390American Depositary Shares→ 931,962 held
Insiders on this tape
- Gillis StevenDirector
- Maraganore JohnDirector
- Reed Kimberly A.Director
- Iijima MasamiDirector
- Broussard Bruce DDirector
- Stoffels PaulusDirector
- Kimura KoichiroDirector
- Tsusaka MikiDirector
- Miyabashira AsukaPresident, Japan Pharma B.U.
- Furuta MilanoChief Financial Officer · Director
- Platford Giles RichardPresident, IBU
- Smoter Jennifer MarieChief Comm. & Gov. Officer
- Ibrahim Ramy Riad AhmedPresident, PDT BU
- Greenway Nicola Deidre PetalChief Human Resources Officer
- Farajallah Awny Samaan BotrosChief Medical Officer
- Furney Natalie Anne MarieGlobal General Counsel
- Pacheco Rhonda JanicePresident, U.S. Business Unit
- Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev.
- Ricci GabrieleChief Data & Tech. Officer
- Shannon Elaine MaryPres., Global Supply & Quality
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.